Intrinsic Value of S&P & Nasdaq Contact Us

Diffusion Pharmaceuticals Inc. DFFN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — DFFN

Diffusion Pharmaceuticals Inc. (DFFN) has a market capitalization of $8.98M and trades at $4.40. The 52-week range is 4.139999-14.37.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.5, Earnings Per Share (EPS) of $-2.98.

The stock has a beta of 1.76, operates in the Healthcare sector.

Trading Data
Current Price$4.40
52-Week Range4.139999-14.37
Volume349.45K
Avg Volume (30D)47.81K
Market Cap$8.98M
Beta (1Y)1.76
Company
IPO Date2008-05-23
Employees13
CEORobert J. Cobuzzi Jr.,
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS15713L1098
CUSIP253748305
Income (Latest Year)
EBITDA$-28.29M
Operating Income$-28.29M
Net Income$-26.97M
EPS$-2.98
EPS Diluted$-2.98
Shares Outstanding$9.04M
Balance Sheet (Latest Year)
Total Assets$22.88M
Current Assets$22.88M
Cash & ST Investments$20.86M
Total Liabilities$4.66M
Net Debt$-8.24M
Total Equity$18.22M
Valuation Ratios
P/E Ratio-1.5
P/B Ratio0.49
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message